Class information for:
Level 1: DONEPEZIL//RIVASTIGMINE//GALANTAMINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
2910 2116 38.2 73%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
49 3       ALZHEIMERS DISEASE//AMYOTROPHIC LATERAL SCLEROSIS//DEMENTIA 92146
259 2             DEMENTIA//MILD COGNITIVE IMPAIRMENT//ALZHEIMERS DISEASE 19619
2910 1                   DONEPEZIL//RIVASTIGMINE//GALANTAMINE 2116

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DONEPEZIL authKW 1680993 15% 36% 326
2 RIVASTIGMINE authKW 1645883 10% 51% 222
3 GALANTAMINE authKW 1168837 9% 44% 186
4 CHOLINESTERASE INHIBITORS authKW 1100385 13% 27% 281
5 MEMANTINE authKW 554436 9% 19% 199
6 ALZHEIMERS DISEASE authKW 291198 44% 2% 929
7 GLENPOINTE W address 265126 1% 88% 21
8 ACETYLCHOLINESTERASE INHIBITORS authKW 203761 5% 13% 107
9 SEVERE IMPAIRMENT BATTERY authKW 129854 1% 75% 12
10 ADAS COG authKW 127187 1% 38% 23

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Geriatrics & Gerontology 44028 25% 1% 521
2 Clinical Neurology 14430 36% 0% 768
3 Gerontology 12680 10% 0% 215
4 Psychiatry 10935 26% 0% 558
5 Pharmacology & Pharmacy 2834 23% 0% 488
6 Neurosciences 974 15% 0% 311
7 Medicine, General & Internal 758 10% 0% 217
8 Pathology 395 5% 0% 96
9 Psychology 191 3% 0% 54
10 Psychology, Clinical 151 2% 0% 50

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GLENPOINTE W 265126 1% 88% 21
2 MEMORY ASSESSMENT 120380 1% 38% 22
3 CLIN ALZHEIMERS DIS RELATED DISORDERS 83475 0% 64% 9
4 MCGILL STUDIES AGING 47470 1% 15% 22
5 KINGSHILL 42567 1% 27% 11
6 CNS AREA 38474 0% 67% 4
7 ALZHEIMERS DIS MEMORY DISORDERS 34610 1% 20% 12
8 BIOMETR BIOSTAT 32977 0% 57% 4
9 GERIATR PSYCHIAT 32532 2% 5% 46
10 ALZHEIMERS DIS MANAGEMENT TEAM 32464 0% 75% 3

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ALZHEIMER DISEASE & ASSOCIATED DISORDERS 87061 4% 7% 92
2 DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 72377 5% 5% 97
3 INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY 29397 4% 2% 89
4 ALZHEIMERS RESEARCH & THERAPY 16406 1% 6% 20
5 ALZHEIMERS & DEMENTIA 16369 1% 4% 31
6 DRUGS & AGING 14262 2% 2% 44
7 AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS 13452 1% 4% 25
8 JOURNAL OF ALZHEIMERS DISEASE 11407 3% 1% 60
9 INTERNATIONAL PSYCHOGERIATRICS 8773 2% 2% 35
10 CNS DRUGS 8414 2% 2% 32

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 DONEPEZIL 1680993 15% 36% 326 Search DONEPEZIL Search DONEPEZIL
2 RIVASTIGMINE 1645883 10% 51% 222 Search RIVASTIGMINE Search RIVASTIGMINE
3 GALANTAMINE 1168837 9% 44% 186 Search GALANTAMINE Search GALANTAMINE
4 CHOLINESTERASE INHIBITORS 1100385 13% 27% 281 Search CHOLINESTERASE+INHIBITORS Search CHOLINESTERASE+INHIBITORS
5 MEMANTINE 554436 9% 19% 199 Search MEMANTINE Search MEMANTINE
6 ALZHEIMERS DISEASE 291198 44% 2% 929 Search ALZHEIMERS+DISEASE Search ALZHEIMERS+DISEASE
7 ACETYLCHOLINESTERASE INHIBITORS 203761 5% 13% 107 Search ACETYLCHOLINESTERASE+INHIBITORS Search ACETYLCHOLINESTERASE+INHIBITORS
8 SEVERE IMPAIRMENT BATTERY 129854 1% 75% 12 Search SEVERE+IMPAIRMENT+BATTERY Search SEVERE+IMPAIRMENT+BATTERY
9 ADAS COG 127187 1% 38% 23 Search ADAS+COG Search ADAS+COG
10 RIVASTIGMINE PATCH 88375 0% 88% 7 Search RIVASTIGMINE+PATCH Search RIVASTIGMINE+PATCH

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 RAINA, P , SANTAGUIDA, P , ISMAILA, A , PATTERSON, C , COWAN, D , LEVINE, M , BOOKER, L , OREMUS, M , (2008) EFFECTIVENESS OF CHOLINESTERASE INHIBITORS AND MEMANTINE FOR TREATING DEMENTIA: EVIDENCE REVIEW FOR A CLINICAL PRACTICE GUIDELINE.ANNALS OF INTERNAL MEDICINE. VOL. 148. ISSUE 5. P. 379-W85 81 64% 305
2 DEARDORFF, WJ , GROSSBERG, GT , (2016) PHARMACOTHERAPEUTIC STRATEGIES IN THE TREATMENT OF SEVERE ALZHEIMER'S DISEASE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 17. ISSUE 13. P. 1789 -1800 68 82% 1
3 DEARDORFF, WJ , FEEN, E , GROSSBERG, GT , (2015) THE USE OF CHOLINESTERASE INHIBITORS ACROSS ALL STAGES OF ALZHEIMER'S DISEASE.DRUGS & AGING. VOL. 32. ISSUE 7. P. 537 -547 60 86% 9
4 BIRKS, JS , EVANS, JG , (2015) RIVASTIGMINE FOR ALZHEIMER'S DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - 64 81% 7
5 ATRI, A , STERN, TA , (2015) PSYCHOPHARMACOLOGIC AGENTS TO ENHANCE COGNITION IN ALZHEIMER'S DISEASE.PSYCHIATRIC ANNALS. VOL. 45. ISSUE 7. P. 354 -367 72 73% 0
6 BIRKS, JS , CHONG, LY , EVANS, JG , (2015) RIVASTIGMINE FOR ALZHEIMER'S DISEASE.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - 63 81% 0
7 DI SANTO, SG , PRINELLI, F , ADORNI, F , CALTAGIRONE, C , MUSICCO, M , (2013) A META-ANALYSIS OF THE EFFICACY OF DONEPEZIL, RIVASTIGMINE, GALANTAMINE, AND MEMANTINE IN RELATION TO SEVERITY OF ALZHEIMER'S DISEASE.JOURNAL OF ALZHEIMERS DISEASE. VOL. 35. ISSUE 2. P. 349 -361 60 73% 34
8 MAXWELL, CJ , STOCK, K , SEITZ, D , HERRMANN, N , (2014) PERSISTENCE AND ADHERENCE WITH DEMENTIA PHARMACOTHERAPY: RELEVANCE OF PATIENT, PROVIDER, AND SYSTEM FACTORS.CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. VOL. 59. ISSUE 12. P. 624 -631 64 74% 6
9 GELDMACHER, DS , FROLICH, L , DOODY, RS , ERKINJUNTTI, T , VELLAS, B , JONES, RW , BANERJEE, S , LIN, P , SANO, M , (2006) REALISTIC EXPECTATIONS FOR TREATMENT SUCCESS IN ALZHEIMER'S DISEASE.JOURNAL OF NUTRITION HEALTH & AGING. VOL. 10. ISSUE 5. P. 417 -429 71 76% 50
10 WONG, CW , (2016) PHARMACOTHERAPY FOR DEMENTIA: A PRACTICAL APPROACH TO THE USE OF CHOLINESTERASE INHIBITORS AND MEMANTINE.DRUGS & AGING. VOL. 33. ISSUE 7. P. 451 -460 50 77% 1

Classes with closest relation at Level 1


Rank Class id link
1 14330 INFORMAL CARE//RUD//CARERQOL INSTRUMENT
2 19745 MEMANTINE//AMANTADINE//UNCOMPETITIVE ANTAGONIST
3 10092 TACRINE//METRIFONATE//TETRAHYDROAMINOACRIDINE
4 21888 KUNGSHOLMEN PROJECT//AD CLINICAL COURSE//ALDRE
5 741 BPSD//NEUROPSYCHIATRIC SYMPTOMS//DEMENTIA
6 17007 INSTRUMENTAL ACTIVITIES OF DAILY LIVING//EVERYDAY FUNCTIONING//ACTIVITIES OF DAILY LIVING
7 2765 BUTYRYLCHOLINESTERASE//ACETYLCHOLINESTERASE//ACETYLCHOLINESTERASE INHIBITORS
8 6640 CLOCK DRAWING TEST//CLOCK DRAWING//MEMORY CLINIC
9 3219 MILD COGNITIVE IMPAIRMENT//MCI//FREE AND CUED SELECTIVE REMINDING TEST
10 1503 COGNITIVE RESERVE//DEMENTIA//BRAIN RESERVE

Go to start page